Autofluorescence and Indocyanine Green to Avoid Hypocalcemia After Thyroidectomy — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Autofluorescence and Indocyanine Green to Avoid Hypocalcemia After Thyroidectomy — Stella

Home/Thyroid Disease/

View on ClinicalTrials.gov

Recruiting

Back to Thyroid Disease trials

Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.

Trial locations(1 site)

Belgium

Onze Lieve Vrouw Hospital, Aalst

Key details

Phase

Large-scale testing

Sponsor

Onze Lieve Vrouw Hospital

Enrollment target

~300 participants

Started

November 2021

Primary completion

October 2024

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

18 Years and older

Last updated April 2024

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.